Journal
CYTOMETRY PART A
Volume 97, Issue 7, Pages 668-673Publisher
WILEY
DOI: 10.1002/cyto.a.24009
Keywords
SARS-CoV-2; Covid-19; coronavirus; biosafety; cytokines; cytometry
Categories
Ask authors/readers for more resources
The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available